78.49
[1]. Alessandro Antonelli, et al. CLM9, a multi-target pyrazolopyrimidine derivative, has anti-neoplastic activity in medullary thyroid cancer in vitro and in vivo. Mol Cell Endocrinol. 14 Aug 5;9(1-):56-64.
H15-H19
P64-P8-P+P5-P6
GHS7
![]()
![]()